KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Long-Term Investments (2016 - 2026)

Sarepta Therapeutics has reported Long-Term Investments over the past 13 years, most recently at $1.0 million for Q4 2025.

  • For Q4 2025, Long-Term Investments fell 99.21% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, down 99.21%, while the annual FY2025 figure was $1.0 million, 99.21% down from the prior year.
  • Long-Term Investments for Q4 2025 was $1.0 million at Sarepta Therapeutics, down from $8.2 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $391.0 million in Q1 2025 and troughed at $1.0 million in Q4 2025.
  • A 5-year average of $52.1 million and a median of $18.5 million in 2022 define the central range for Long-Term Investments.
  • On a YoY basis, Long-Term Investments climbed as much as 5143.4% in 2025 and fell as far as 99.21% in 2025.
  • Year by year, Long-Term Investments stood at $34.9 million in 2021, then dropped by 10.23% to $31.3 million in 2022, then tumbled by 76.05% to $7.5 million in 2023, then skyrocketed by 1675.51% to $133.2 million in 2024, then crashed by 99.21% to $1.0 million in 2025.
  • Business Quant data shows Long-Term Investments for SRPT at $1.0 million in Q4 2025, $8.2 million in Q3 2025, and $195.5 million in Q2 2025.